|
|
|
Industry Dynamics
The pharmaceutical industry is undergoing a redefining transformation. Rising costs and demands for affordable healthcare combined with lower tolerance for therapeutic risk are challenging the economics and traditional business assumptions of the industry. Pipelines have been dwindling, blockbuster patents are expiring, and new products launched in their place are not expected to attain historical profit growth rates. New product investment decisions are complicated by the uncertain timing of global breakthroughs within major technological platforms, such as genomics, that are expected to revolutionize the industry. Finally, growing skepticism about industry integrity has translated into new regulatory and legal requirements for transparency.
read more
Business Challenges
This highly dynamic market is challenging the traditional business model that was once so successful. The growing limitations, increasing expenses and declining results of the established product-driven business model are leading to the emergence of a new, market-driven approach to the industry that addresses the needs and interests of all critical stakeholders.
read more
Our Depth of Knowledge
Over the last 20 years we’ve worked across a wide variety of industries understanding changing market dynamics and influence mechanisms, and translating this knowledge into effective strategy and breakthrough results. Our work with pharmaceutical companies, payors, hospitals and physicians positions us to help our clients understand the complex relationship needs of all key stakeholders, and to use this perspective to shape responsive strategy.
read more
|
|
|
|